The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study
Abstract
Objective: Pituitary adenomas (PA) are among the most common human neoplasms. To describe the epidemiology and assess the disease burden of clinically significant PAs, population-based studies are needed. Iceland has a small well-defined population. The aim of this study is to describe the epidemiology of PAs in Iceland over an expanded period of time. Design: This is a retrospective observational study, including all PAs diagnosed in Iceland from 1955 to 2012. Methods: Extensive clinical information was gathered in a database. Prevalence rates for all PA subtypes were calculated along with standardized incidence rates (SIR). Sex ratios and relationships with adenoma size, age, and symptoms were assessed. Results: We identified 471 individuals: 190 men and 281 women. Total prevalence in 2012 was 115.57/100 000, prolactinomas were most prevalent (54.37/100 000) followed by non-functioning adenomas (NFPAs) (42.32/100 000). Throughout the period, NFPAs were most common (43.0%) followed by prolactinomas (39.9%) and 11.3% had acromegaly and 5.7% Cushing's disease. Women are diagnosed younger with smaller adenomas. Total SIR has increased significantly and is now 5.8/100 000 per year. Conclusion: In this nationwide study spanning six decades, we have confirmed PAs rising prevalence and incidence rates noted in recent studies. We demonstrated higher overall prevalence and incidence rates than ever previously recorded with an increasing predominance of NFPAs, which is not explained by incidental findings alone. There is a relationship with the introduction of imaging modalities, but the vast majority of patients are symptomatic at diagnosis. This underlines the importance of increased awareness, education, and appropriate allocation of resources for this growing group of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Ostrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou223 · Cited by 1,718
The prevalence of pituitary adenomas: A systematic review
Ezzat, S., Asa, S. L., Couldwell, W. T., Barr, C. E., Dodge, W. E., Vance, M. L., & McCutcheon, I. E. (2004) · Cancer · doi:10.1002/cncr.20412 · Cited by 1,345
Fernandez, A., Karavitaki, N., & Wass, J. A. H. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03667.x · Cited by 1,115
High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liège, Belgium
Daly, A. F., Rixhon, M., Adam, C., Dempegioti, A., Tichomirowa, M. A., & Beckers, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1668 · Cited by 1,025
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Age standardization of rates: a new WHO standard (GPE discussion paper Series: No. 31)
Ahmad, O., Boschi-Pinto, C., López, A. D., Murray, C. O., Lozano, R., Inoue, M., & Ahmad, O. R. A. (2002) · Cited by 844
Guidelines for Acromegaly Management: An Update
Melmed, S., Colao, A., Barkan, A., Molitch, M., Grossman, A. B., Kleinberg, D., Clemmons, D., Chanson, P., Laws, E., Schlechte, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2421 · Cited by 764
Incidence of Pituitary Adenomas in Northern Finland in 1992–2007
Raappana, A., Koivukangas, J., Ebeling, T., & Pirilä, T. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0537 · Cited by 470
Guidelines for Acromegaly Management
Melmed, S., Casanueva, F. F., Cavagnini, F., Chanson, P., Frohman, L., Grossman, A., Ho, K., Kleinberg, D., Lamberts, S., Laws, E., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-011841 · Cited by 343
Subclinical Adenoma of the Pituitary Gland.
Costello, R. T. (1936) · PubMed Central · Cited by 324
Prevalence and incidence of pituitary adenomas: a population based study in Malta
Gruppetta, M., Mercieca, C., & Vassallo, J. (2013) · Pituitary · doi:10.1007/s11102-012-0454-0 · Cited by 229
HYPERPROLACTINAEMIA AND IMPOTENCE
Franks, S., Jacobs, H. S., Martin, N., & Nabarro, J. D. N. (1978) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1978.tb02770.x · Cited by 197
Descriptive epidemiology of pituitary tumors in the United States, 2004–2009: Clinical article
Gittleman, H., Ostrom, Q. T., Farah, P. D., Ondracek, A., Chen, Y., Wolinsky, Y., Kruchko, C., Singer, J., Kshettry, V. R., Laws, E. R., et al. (2014) · Journal of Neurosurgery · doi:10.3171/2014.5.jns131819 · Cited by 182
Van Der Klaauw, A. A., Kars, M., Biermasz, N. R., Roelfsema, F., Dekkers, O. M., Corssmit, E. P., Van Aken, M. O., Havekes, B., Pereira, A. M., Pijl, H., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03288.x · Cited by 175
Quality of Life Is Decreased after Treatment for Nonfunctioning Pituitary Macroadenoma
Dekkers, O. M., van der Klaauw, A. A., Pereira, A. M., Biermasz, N. R., Honkoop, P., Roelfsema, F., Smit, J. W. A., & Romijn, J. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0003 · Cited by 135
PREVALENCE AND PRESENTATION OF HYPERPROLACTINÆMIA IN PATIENTS WITH "FUNCTIONLESS" PITUITARY TUMOURS
Franks, S., Nabarro, J. D. N., & Jacobs, H. S. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92959-2 · Cited by 109
Pituitary Adenomas in Sweden between 1958 and 1991: Incidence, Survival, and Mortality
Nilsson, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.4.1420 · Cited by 107
Matta, M., Couture, E., Cazals, L., Vezzosi, D., Bennet, A., & Caron, P. J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0697 · Cited by 105
[Epidemiology of pituitary adenoma: results of the first Swiss study].
Fontana, E., & Gaillard, R.-C. (2009) · PubMed · Cited by 90
Sporadic pituitary tumours: from epidemiology to use of databases
Clayton, R. N. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0036 · Cited by 45
Multigenerational Information: The Example of the Icelandic Genealogy Database
Tulinius, H. (2010) · Methods in molecular biology · doi:10.1007/978-1-59745-423-0_11 · Cited by 14
Cited by
Diagnosis and Treatment of Pituitary Adenomas: A Review
Molitch, M. E. (2017) · JAMA · doi:10.1001/jama.2016.19699 · Cited by 933
Pituitary-Tumor Endocrinopathies
Melmed, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1810772 · Cited by 604
Colao, A., Grasso, L. F. S., Giustina, A., Melmed, S., Chanson, P., Pereira, A. M., & Pivonello, R. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0071-6 · Cited by 396
Diagnosis and Management of Pituitary Adenomas: A Review
Tritos, N. A., & Miller, K. K. (2023) · JAMA · doi:10.1001/jama.2023.5444 · Cited by 331
The Epidemiology of Pituitary Adenomas
Daly, A. F., & Beckers, A. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.04.002 · Cited by 325
Metadata
- Authors
- Agustsson, T. T., Baldvinsdottir, T., Jonasson, J. G., Olafsdottir, E., Steinthorsdottir, V., Sigurdsson, G., Thorsson, A. V., Carroll, P. V., Korbonits, M., & Benediktsson, R.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-11
- Volume
- 173
- Issue
- 5
- Pages
- 655-664
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2238072587
- Cited by
- 347
- References
- 23
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.